FMP
NASDAQ
0.696 USD
0.0013 (0.187%)
Dr. Paul A. Wagner Ph.D.
Healthcare
Biotechnology
https://www.fortebiorx.com
NASDAQ
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
0001419041
US34962G1094
34962G109
3060 Pegasus Park Drive
310 618 6994
US
9
Apr 13, 2017